Shanghai, China - Shanghai MicroPort Medical (Group) Co., Ltd. ('MicroPort') was recently selected as 'Shanghai Five-Star Credit Enterprise' by Shanghai Credibility Construction Program Committee under Shanghai Municipal Government. MicroPort was awarded the highest honor of Shanghai Credibility Construction Program for the second consecutive year.

Under the direction of 20 departments of Shanghai Municipal Government including Shanghai Publicity Department, Shanghai Civilization Office, Shanghai Municipal Commission of Economy and Information, Shanghai Credibility Construction Program is designed to promote the construction of Shanghai credibility system and improve the intangible infrastructure of Shanghai's economic and social development.

Integrity is one of MicroPort's eight key values and the pursuit of excellence has been deeply rooted in MicroPort's corporate culture. In this selection, MicroPort obtained the highest AAA ranting in the credibility assessment report issued by independent third parties, with its scores of every indicator on top of all the candidates. This five-star award showed that MicroPort's effort in building up an integrity system in the company was fully recognized by the committee and the society.

MicroPort will continue to apply the core value 'integrity' to our strategic vision and development goal, and MicroPort employees are determined to demonstrate our integrity through quality products and service, to help drive the company's future.

About MicroPort

MicroPort Scientific Corporation (the 'Group') is a leading medical device company with business focusing on innovating, manufacturing, and marketing high-quality and high-end medical devices globally. With a diverse portfolio of products now being used at an average rate of one for every 15 seconds in thousands of major hospitals around the world, the Group maintains world-wide operations in a broad range of business segments including Cardiovascular, Orthopedic, Electrophysiological, Endovascular, Neurovascular, Surgical, Diabetes Care and Endocrinal Management, and others. MicroPort is dedicated to becoming a patient oriented global enterprise improve and reshape patient lives through application of innovative science and technology.

For more information, please refer to: www.microport.com

Forward-Looking Statements

Some information contained on this website contains forward-looking statements. These forward-looking statements include, without limitation, those regarding our future financial position, our strategy, plans, objectives, goals and targets, future developments in the markets where we participate or are seeking to participate, and any statements preceded by, followed by or that include the words 'believe', 'intend', 'expect', anticipate', 'project', 'estimate', 'predict', 'is confident', 'has confidence' and similar expressions are also intended to identify forward-looking statements. Such statements are based upon the current beliefs and expectations of MicroPort's management and are subject to significant risks and uncertainties. MicroPort Scientific Corporation undertakes no obligation to update any of the statements. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors that could cause actual future results to differ materially from current expectations include, but are not limited to, general industry and economic conditions, PRC governmental policies and regulations relating to the medical device manufacturing industry, competition in the medical device manufacturing industry, our ability to develop new products and stay abreast of market trends and technological advances, our goals and strategies, our ability to execute strategic acquisitions of, investments in or alliances with other companies and businesses, fluctuations in general economic and business conditions in China.

This document is for information purposes only and does not constitute or form part of any offer or invitation to sell or the solicitation of an offer or invitation to purchase or subscribe for any securities of MicroPort Scientific Corporation, and no part of it shall form the basis of, or be relied upon in connection with, any agreement, arrangement, contract, commitment or investment decision in relation thereto whatsoever.

All rights reserved.
Copyright © 2017 MicroPort Scientific Corporation

CONTACT:
Sophie Wei
Senior Corporate Culture Manager
Shanghai MicroPort Medical (Group) Co., Ltd. (HQ)
Tel: (86)(21) 38954600-8018
Email: spokesperson@microport.com

MicroPort Scientific Corporation published this content on 22 January 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 22 January 2017 00:45:06 UTC.

Original documenthttp://www.microport.com.cn/en/media.php?curr_page=news_details&id=461

Public permalinkhttp://www.publicnow.com/view/FD0EEAB2A727B565D0AE68A70FA318618FE43DC4